戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ring intraoperative GDFT versus conventional fluid therapy.
2 went GDFT and 1059 who received conventional fluid therapy.
3 ce of using central venous pressure to guide fluid therapy.
4 which has led to the advent of goal-directed fluid therapy.
5 d acute lung injury and were not affected by fluid therapy.
6 on of supplemental-oxygen and/or intravenous-fluid therapy.
7 Mortality in FVB mice was fully prevented by fluid therapy.
8 w colloids', and on the amount and timing of fluid therapy.
9 s for mice that received only antibiotic and fluid therapy.
10  deaths at 90 days than standard intravenous fluid therapy.
11  to an acute illness, and needed intravenous fluid therapy.
12 atients (1.3%) receiving plasmalike isotonic fluid therapy.
13 , and SIRS persistence than moderate or high fluid therapy.
14                  Restrictive vs. standard IV fluid therapy.
15 -fold greater in children receiving isotonic fluid therapy.
16  mL/kg is a key target guiding perioperative fluid therapy.
17 e commercially available plasmalike isotonic fluid therapy (140 mmol/L of sodium and 5 mmol/L potassi
18   In the alert group, more patients received fluid therapy (23.0% vs. 4.9% and 9.2%, p mu .01), diure
19 gnificantly greater in patients who received fluid therapy (26.9 +/- 12.5% vs 6.2 +/- 4.3%; p < 0.000
20 on in children receiving plasmalike isotonic fluid therapy (61 of 308 patients [20%]) compared with t
21 sium in 5% dextrose) or moderately hypotonic fluid therapy (80 mmol/L sodium and 20 mmol/L potassium
22 ed with those receiving moderately hypotonic fluid therapy (9 of 306 patients [2.9%]; 95% CI of the d
23  NT-Pro-BNP changes and its association with fluid therapy and CPC.
24 hat incorporates quantitative projections of fluid therapy and fluid losses on the patient's serum so
25          All patients received goal-directed fluid therapy and hemodynamic management if they had a m
26 est further vomiting and prevent intravenous fluid therapy and hospitalization aids children with vom
27  of vomiting, decreased need for intravenous fluid therapy and hospitalizations, without serious adve
28  an overview of the history of perioperative fluid therapy and its relevance to modern practice.Intra
29 t also highlight concomitant improvements in fluid therapy, antibiotics, and intensive care.
30 ed as a 10% increase in cardiac output after fluid therapy, assessed by a second transthoracic echoca
31 e PICU and considered to require intravenous fluid therapy by the treating clinician were eligible.
32                                              Fluid therapy can be conceptualized as 4 overlapping pha
33 ugs, as well as cardiovascular, hormonal and fluid therapies, can all influence the ability to fast-t
34 r in children receiving isotonic, plasmalike fluid therapy compared with those receiving mildly hypot
35  previously widely used moderately hypotonic fluid therapy containing 20 mmol/L of potassium.
36 aoperative strategies, such as goal-directed fluid therapy, could mitigate the impact of POAF.
37                                              Fluid therapy directed at preset hemodynamic goals with
38 er integrity, or affecting immune responses, fluid therapy (FT) fully rescues Il22(-/-) mice by corre
39 aluate the quality of current evidence about fluid therapy (FT) in acute pancreatitis (AP).
40                                              Fluid therapy fully prevented mortality in C3H/HeOu and
41 review and meta-analysis to evaluate whether fluid therapy guided by dynamic assessment of fluid resp
42 nistration until very recently.Newer work in fluid therapy has explored the concept of fluid restrict
43 olutions, the renewed focus on perioperative fluid therapy has led to IVF administration being guided
44 o < 20 ml/kg/h), and low (5 to < 10 ml/kg/h) fluid therapy in acute pancreatitis were considered.
45 nic crystalloids are recommended for initial fluid therapy in acute pancreatitis, but whether the use
46 en, but there is limited evidence of optimal fluid therapy in acutely ill children.
47  hypotonic fluid for maintenance intravenous fluid therapy in children?
48 answered questions for future research about fluid therapy in critical illness.
49                                    Excessive fluid therapy in patients with sepsis may be associated
50        This has implications for intravenous fluid therapy in perioperative and critically ill patien
51         Among patients receiving crystalloid fluid therapy in the ICU, use of a buffered crystalloid
52  receive BMES (Plasma-Lyte 148) or saline as fluid therapy in the intensive care unit (ICU) for 90 da
53                                              Fluid therapy in the operating room and on the ICU direc
54         Other than cell washing, intravenous fluid therapy is an essential medical practice in hospit
55                                              Fluid therapy is an important component of care for pati
56                          The use of isotonic fluid therapy is currently recommended in children, but
57                                  Intravenous fluid therapy is the most common intervention received b
58 gan perfusion are evaluated); stabilization (fluid therapy is used only when there is a signal of flu
59 , commercially available plasmalike isotonic fluid therapy markedly increased the risk for clinically
60  In the Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care (CLASSIC
61 fference was found between moderate and high fluid therapy (OR = 0.59; 95% CI [0.41, 0.86]; p = 0.006
62 d clinical outcomes with low versus moderate fluid therapy (OR = 0.73; 95% CI [0.13, 4.03]; p = 0.71)
63 plications improved with moderate versus low fluid therapy (OR = 1.22; 95% CI [0.84, 1.78]; p = 0.29)
64 ed intravenous fluid or standard intravenous fluid therapy; patients were included if the onset of sh
65 he relative increase in cardiac output after fluid therapy (r = 0.44; p = 0.019).
66 ffered solution) administered as intravenous fluid therapy reduced the incidence of rise in plasma ch
67 ck cancer in a prospective and goal-directed fluid therapy setting.
68                                              Fluid therapy-the administration of fluids to maintain a
69                                        While fluid therapy typically begins in the emergency departme
70    In conclusion, PPV is useful for managing fluid therapy under specific conditions where it is reli
71     Hemodynamic monitoring and goal-directed fluid therapy using the PiCCO system was done.
72 9 [95% CI, 1.2-140]; p = 0.04) and cumulated fluid-therapy volume greater than 10.7 L (odds ratio, 16
73 or prehospital exposure time and intravenous fluid therapy was also evaluated.
74                        In the control group, fluid therapy was directed by maximizing stroke volume i
75                                  High-volume fluid therapy was independently associated with poorer o
76                                              Fluid therapy was prescribed to patients exhibiting one
77 ts admitted to the ICU requiring crystalloid fluid therapy were eligible for inclusion.
78 an 3.0 mmol/L on admission; clinical need of fluid therapy with 10% glucose solution; a history of di
79  BIA in monitoring body water changes during fluid therapy with ECMO support.
80 ecal ligature and puncture (CLP) surgery and fluid therapy with or without NButGT.
81                 In cardiac surgery patients, fluid therapy with perioperative administration of synth